Form SC 13G Assertio Therapeutics, Filed by: D. E. SHAW & CO, L.P.
Assertio Holdings, Inc. (ASRT)
Last assertio holdings, inc. earnings: 3/9 04:02 pm
Check Earnings Report
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
ASRT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASRT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASRT alerts
High impacting Assertio Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ASRT
News
- Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors [Yahoo! Finance]Yahoo! Finance
- Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of DirectorsGlobeNewswire
- Assertio Holdings, Inc. (NASDAQ: ASRT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.MarketBeat
- Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical StudyGlobeNewswire
- Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO [Yahoo! Finance]Yahoo! Finance
ASRT
Earnings
- 11/11/24 - Beat
ASRT
Sec Filings
- 12/17/24 - Form 8-K
- 11/19/24 - Form 4
- 11/15/24 - Form 4
- ASRT's page on the SEC website